Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Burden of Thyroid Cancer in North Africa and Middle East 1990–2019 Publisher



Nejadghaderi SA1 ; Moghaddam SS1 ; Azadnajafabad S1 ; Rezaei N1, 2 ; Rezaei N1, 2 ; Tavangar SM3 ; Jamshidi H4 ; Mokdad AH5, 6 ; Naghavi M5, 6 ; Farzadfar F1, 2 ; Larijani B2 ; Abbasikangevari Z1, 7 ; Abdollahzade S8 ; Abugharbieh E9 Show All Authors
Authors
  1. Nejadghaderi SA1
  2. Moghaddam SS1
  3. Azadnajafabad S1
  4. Rezaei N1, 2
  5. Rezaei N1, 2
  6. Tavangar SM3
  7. Jamshidi H4
  8. Mokdad AH5, 6
  9. Naghavi M5, 6
  10. Farzadfar F1, 2
  11. Larijani B2
  12. Abbasikangevari Z1, 7
  13. Abdollahzade S8
  14. Abugharbieh E9
  15. Afrashteh S10, 11
  16. Afzal MS12
  17. Ahmad S13
  18. Abbasikangevari M1
  19. Ahmadi A14, 15
  20. Ahmadi S16
  21. Ahmed H17
  22. Ahmed LA18
  23. Al Hamad H19, 20
  24. Alhalaiqa FAN21, 22
  25. Alvand S23
  26. Amlashi FI24
  27. Anoushirvani AA25
  28. Arabloo J26
  29. Athari SS27
  30. Azangoukhyavy M1, 7
  31. Jafari AA28
  32. Bijani A29
  33. El Sayed I30
  34. Elbarazi I18
  35. Elhadi M31
  36. Faris PS32, 33
  37. Farmany A34
  38. Fatehizadeh A35
  39. Ghamari A2
  40. Ghamari SH1, 7
  41. Ghashghaee A36
  42. Goleij P37
  43. Golitaleb M38
  44. Hajmirzaian A39, 40
  45. Halwani R9, 41
  46. Hamidi S42
  47. Hassanipour S43, 44
  48. Househ M45
  49. Javaheri T46
  50. Kavetskyy T47, 48
  51. Khalilov R49, 50
  52. Khan EA51
  53. Khanali J1, 7
  54. Khayamzadeh M52, 53
  55. Kolahi AA7, 54
  56. Koohestani HR55
  57. Livani S56
  58. Malekpour MR1
  59. Malik AA57, 58
  60. Nasab EM59
  61. Mirmoeeni S28
  62. Mohammad Y60
  63. Mohammadi E1, 61
  64. Mohammadianhafshejani A14
  65. Momtazmanesh S1, 62
  66. Moraga P63
  67. Natto ZS64, 65
  68. Noori M66
  69. Nowroozi A62
  70. Kan FP67
  71. Piracha ZZ68
  72. Rafiei S69
  73. Ramezanzadeh K39
  74. Rashidi M70
  75. Rashidi MM1, 7
  76. Rawassizadeh R71
  77. Rezaei N1, 2
  78. Rezazadehkhadem S1
  79. Saddik B74
  80. Saeed U75, 76
  81. Sahebkar A77, 78
  82. Samy AM79
  83. Nadeem Saqib MA80, 81
  84. Sathian B19, 82
  85. Shahabi S83
  86. Shahin S1
  87. Shaker E1, 62
  88. Sharifirad J84
  89. Shobeiri P1, 62
  90. Taheriabkenar Y84
  91. Talaat IM9, 85
  92. Ullah I12, 86
  93. Valizadeh R87
  94. Vo B88
  95. Yuce D89
  96. Zare I90

Source: Frontiers in Oncology Published:2022


Abstract

Background: Thyroid cancer is the leading cause of mortality and morbidity among cancers of the endocrine system. We aimed to describe the trends of thyroid cancer burden in North Africa and Middle East for 1990–2019. Methods: Data on burden of thyroid cancer in North Africa and Middle East from 1990 to 2019 were obtained from the Global Burden of Disease (GBD) Study 2019. Decomposition analysis was used to estimate the effects of population growth, aging, and change in incident numbers on overall change of thyroid cancer incidence. Also, we used the comparative risk assessment framework of GBD to determine the burden of thyroid cancer attributable to a high body mass index (BMI). Results: In 2019, the age-standardized incidence rate (ASIR) and age-standardized mortality rate (ASMR) of thyroid cancer were 3.5 (2.9–4) and 0.5 (0.5–0.7) per 100,000, respectively. The highest age-standardized incidence, deaths, and disability-adjusted life year (DALY) rate were in Lebanon, Afghanistan, and United Arab Emirates, respectively. The ASIR of thyroid cancer in region was about 2.5 times higher among women, which had a positive association with increasing age. In 2019, the age-standardized deaths attributable to a high BMI was 16.7% of all deaths due to thyroid cancer. In 1990–2019, the overall change in thyroid cancer incident cases was a 396% increase which was mostly driven by the increase in disease-specific incidence rate (256.8%). Conclusions: Women, the elderly above about 60 years old, and countries with a higher sociodemographic index showed higher incidence rates of thyroid cancer. Regarding our findings, it is recommended to establish preventive plans by modification in life style like weight reduction programs. Copyright © 2022 Nejadghaderi, Moghaddam, Azadnajafabad, Rezaei, Rezaei, Tavangar, Jamshidi, Mokdad, Naghavi, Farzadfar and Larijani.
Other Related Docs
11. Survival of Patients With Thyroid Cancer in Yazd, Iran, Asian Pacific Journal of Cancer Prevention (2017)